Endothelin receptor blockade potentiates adoptive T cell and CAR T cell therapies
Charys Papagregoriou, Fotios Mpekris, Jongwon Yoon, Georgios Kastrappis, Andria A. Lytridou, Maria Thrasyvoulou, Konstantinos Symeonidis, Christina Pitsillidou, Constantina Neophytou, Myrofora Panagi, Chrysovalantis Voutouri, Maria Iakovou, Gregoria Gregoriou, Triantafyllos Stylianopoulos, Paul Michael Maciocia, , Philippos Demetriou
This study shows that blocking the endothelin receptor pathway enhances T cell and CAR T cell therapies in cancer models by improving antitumour responses and durable immunity.
bioRxiv · Sep 6, 2026 · PreprintImmunology